Leading oncology centers presented breakthroughs in radiation therapy including targeted radioactive treatments for recurrent prostate and pancreatic cancers, and long-term data confirming stereotactic body radiation therapy's efficacy equal to surgery for early-stage lung cancer. Novel imaging technologies incorporating MRI and 5DCT guide precision treatment delivery, reflecting a multidisciplinary drive to improve cancer outcomes through innovative radiotherapy modalities.